Vermillion & White Wealth Management Group’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-107
Closed -$2.23K 563
2025
Q4
$2.23K Hold
107
﹤0.01% 491
2025
Q3
$1.68K Hold
107
﹤0.01% 512
2025
Q2
$2.13K Buy
+107
New +$2.17K ﹤0.01% 458

Other funds holding TECX

Vermillion & White Wealth Management Group's TECX Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Tectonic Therapeutic (TECX) in Q1 2026, closing a stake of 107 shares — an estimated $2.23K sold.

Vermillion & White Wealth Management Group first reported a position in TECX in Q2 2025 and held it in 3 quarters. The position peaked at $2.23K in Q4 2025. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Tectonic Therapeutic position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 107 Tectonic Therapeutic shares in Q1 2026, an estimated $2.23K.
  • Vermillion & White Wealth Management Group first reported a position in Tectonic Therapeutic in Q2 2025 and held it in 3 quarters.
  • Vermillion & White Wealth Management Group's Tectonic Therapeutic position peaked at $2.23K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.